Knockout Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Shift Labsshiftlabs.comin𝕏Mar 2023Acquired
Shift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings.
Digital HealthHardwareHealthtechMedical DevicesSeattle, US
Beth Kolko(Founder/CEO)inJoseph Mechlinski(Executive Officer, Director)
Co-investorsSGH CapitalY Combinator
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.